CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors

Bibliographic Details
Main Authors:	Ambrosone, Christine B, Moysich, Kirsten B, Furberg, Helena, Freudenheim, Jo L, Bowman, Elise D, Ahmed, Sabrina, Graham, Saxon, Vena, John E, Shields, Peter G
Format:	Online
Language:	English
Published:	BioMed Central 2003
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC154148/

Similar Items

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study
by: Chang, Jiun-Horng, et al.
Published: (2005)

CYP17 and breast cancer: no overall effect, but what about interactions?
by: Little, Julian, et al.
Published: (2005)

No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer.
by: Dunning, A. M., et al.
Published: (1998)

CYP17 gene polymorphism in relation to breast cancer risk: a case-control study
by: Einarsdóttir, Kristjana, et al.
Published: (2005)

Social Trauma as Related to Cancer of the Breast
by: Snell, Laura, et al.
Published: (1971)

Assessing spatio-temporal variability of risk surfaces using residential history data in a case control study of breast cancer
by: Han, Daikwon, et al.
Published: (2005)

The promise and limitations of genome-wide association studies to elucidate the causes of breast cancer
by: Ambrosone, Christine B
Published: (2007)

Influence of CYP19A1 polymorphisms on the treatment of breast cancer with aromatase inhibitors: a systematic review and meta-analysis
by: Artigalás, Osvaldo, et al.
Published: (2015)

CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case–control study
by: Verla-Tebit, Emaculate, et al.
Published: (2005)

Association of Rad51 polymorphism with DNA repair in BRCA1 mutation carriers and sporadic breast cancer risk
by: Ricks-Santi, Luisel J, et al.
Published: (2011)

Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association study
by: Ahsan, Habibul, et al.
Published: (2005)

Genetic variants of CYP19 (aromatase) and breast cancer risk
by: Nedelcheva Kristensen, V, et al.
Published: (2000)

Letrozole efficacy is related to human aromatase CYP19 single nucleotide polymorphisms (SNPs) in metastatic breast cancer
by: Colomer, R, et al.
Published: (2005)

Association Analysis of IL-17A and IL-17F Polymorphisms in Chinese Han Women with Breast Cancer
by: Wang, Lihong, et al.
Published: (2012)

Genetic Polymorphism of CYP2D6 and MDR1 in breast cancer patients treated with tamoxifen
by: Mohamad, NI, et al.
Published: (2010)

The Risk of Recurrence in Breast Cancer Patients Treated with Tamoxifen: Polymorphisms of CYP2D6 and ABCB1
by: Teh, L. K., et al.
Published: (2011)

Association between Genetic Polymorphisms of CYP2D6 and Outcomes in Breast Cancer Patients with Tamoxifen Treatment
by: Park, Hyung Seok, et al.
Published: (2011)

Simple tandem repeat (TTTA)n polymorphism in CYP19 (aromatase) gene and breast cancer risk in Nigerian women
by: Okobia, Michael N, et al.
Published: (2006)

Risk-Association of CYP11A1 Polymorphisms and Breast Cancer Among Han Chinese Women in Southern China
by: Sun, Minying, et al.
Published: (2012)

Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors
by: Mao, Jun J, et al.
Published: (2011)

CYP2D6 genetic polymorphisms and phenotypes in different ethnicities of Malaysian breast cancer patients
by: Fee, Wai Chin, et al.
Published: (2016)

CYP2D6 polymorphisms influence the efficacy of adjuvant tamoxifen in Thai breast cancer patients
by: Sirachainan, Ekaphop, et al.
Published: (2012)

Influence of CYP2D6 Polymorphisms on Serum Levels of Tamoxifen Metabolites in Spanish Women with Breast Cancer
by: Zafra-Ceres, Mercedes, et al.
Published: (2013)

Association of Single Nucleotide Polymorphisms in CYP1B1 and COMT Genes with Breast Cancer Susceptibility in Indian Women
by: Yadav, Sharawan, et al.
Published: (2009)

Analysis of the rs10046 Polymorphism of Aromatase (CYP19) in Premenopausal Onset of Human Breast Cancer
by: Zins, Karin, et al.
Published: (2014)

Effects of CYP2D6 and UGT2B7 polymorphisms on pharmacokinetics of tamoxifen in Thai breast cancer patients
by: Areepium, N, et al.
Published: (2013)

Association of CYP19 polymorphisms with breast cancer risk: A case-control study
by: Surekha, Damineni, et al.
Published: (2014)

The CYP19 RS4646 Polymorphism IS Related to the Prognosis of Stage I–II and Operable Stage III Breast Cancer
by: Shao, Xiying, et al.
Published: (2015)

Multicentre study of CASP8 polymorphisms in breast cancer
by: Shephard, N, et al.
Published: (2008)

MTHFR polymorphisms and breast cancer risk
by: Hosseini, Mojgan, et al.
Published: (2011)

Does a polymorphism in the CYP17 gene predict mammographic density?
by: Ursin, G, et al.
Published: (2000)

Association between manganese superoxide dismutase promoter gene polymorphism and breast cancer survival
by: Martin, Robert CG, et al.
Published: (2006)

CYP17 T27C polymorphism and prostate cancer risk: a meta-analysis based on 31 studies
by: Wei, Bingbing, et al.
Published: (2010)

Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk
by: Bethke, Lara, et al.
Published: (2007)

MicroRNA Related Polymorphisms and Breast Cancer Risk
by: Khan, Sofia, et al.
Published: (2014)

The consumption of seaweed as a protective factor in the etiology of breast cancer: proof of principle
by: Teas, Jane, et al.
Published: (2012)

Association between cytochrome CYP17A1, CYP3A4, and CYP3A43 polymorphisms and prostate cancer risk and aggressiveness in a Korean study population
by: Han, Jun Hyun, et al.
Published: (2015)

CYP1A2 – a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients
by: Simonsson, Maria, et al.
Published: (2016)

Chromosome 17 copy number changes in male breast cancer
by: Lacle, Miangela M., et al.
Published: (2015)

Genotyping of XRCC1 polymorphisms in breast cancer
by: Nalini Krishnan,
Published: (2008)